Current concepts in portal vein thrombosis: etiology, clinical presentation and management

Sadeer Alzubaidi, Indravadan Patel, Aman Saini, Grace Knuttinen, Sailendra Naidu, Scott Kriegshuaser, Hassan Albadawi, Rahmi Oklu

Research output: Contribution to journalReview article

Abstract

Objective: The aim of this article is to focus on etiology, risk factors, clinical presentation and classification systems of acute and chronic PVT as well as focusing on current diagnostic and therapeutic options for the management of acute and chronic PVT. Results: PVT represents a serious clinical concern in cirrhotic patients and in those with specific local or systemic risk factors. The rate and extent of thrombus formation can significantly impact patient presentation and the resulting clinical outcomes. The presentation of acute PVT can range from abdominal pain to intestinal ischemia/infarction and even death, while chronic PVT can remain clinically silent. A number of imaging modalities including US, CT and MRI can be used to confirm the diagnosis. In addition to addressing underlying risk factors, AC therapy forms a cornerstone of treatment and has demonstrated efficacy in both acute and chronic settings. Proper caution should be used when initiating AC therapy in cirrhotic patients given their underlying coagulopathic status with attention now being paid to NOACs and LMWH. For patients with bowel ischemia, extensive thrombosis, contraindications or poor response to AC, or for those with co-morbidities that preclude AC, minimally invasive endovascular techniques offer alternative treatment options. Conclusion: Familiarity with the etiology, clinical presentation and classification of PVT optimize early detection and incorporate effective therapeutic options, the management of these complex patients should be undertaken by a multidisciplinary team. Minimally invasive catheter-based therapies and endovascular portosystemic shunt creation demonstrated efficacy in the treatment of AC-resistant patients and for patients with extensive or complicated disease.

Original languageEnglish (US)
JournalAbdominal Radiology
DOIs
StateAccepted/In press - Jan 1 2019

Fingerprint

Portal Vein
Thrombosis
Therapeutics
Ischemia
Surgical Portasystemic Shunt
Endovascular Procedures
Low Molecular Weight Heparin
Infarction
Abdominal Pain
Catheters
Morbidity

Keywords

  • Portal hypertension
  • Portal vein thrombosis
  • Transsplenic

ASJC Scopus subject areas

  • Radiological and Ultrasound Technology
  • Radiology Nuclear Medicine and imaging
  • Gastroenterology
  • Urology

Cite this

Current concepts in portal vein thrombosis : etiology, clinical presentation and management. / Alzubaidi, Sadeer; Patel, Indravadan; Saini, Aman; Knuttinen, Grace; Naidu, Sailendra; Kriegshuaser, Scott; Albadawi, Hassan; Oklu, Rahmi.

In: Abdominal Radiology, 01.01.2019.

Research output: Contribution to journalReview article

@article{6b275006a3c943358835c373e02e3ecb,
title = "Current concepts in portal vein thrombosis: etiology, clinical presentation and management",
abstract = "Objective: The aim of this article is to focus on etiology, risk factors, clinical presentation and classification systems of acute and chronic PVT as well as focusing on current diagnostic and therapeutic options for the management of acute and chronic PVT. Results: PVT represents a serious clinical concern in cirrhotic patients and in those with specific local or systemic risk factors. The rate and extent of thrombus formation can significantly impact patient presentation and the resulting clinical outcomes. The presentation of acute PVT can range from abdominal pain to intestinal ischemia/infarction and even death, while chronic PVT can remain clinically silent. A number of imaging modalities including US, CT and MRI can be used to confirm the diagnosis. In addition to addressing underlying risk factors, AC therapy forms a cornerstone of treatment and has demonstrated efficacy in both acute and chronic settings. Proper caution should be used when initiating AC therapy in cirrhotic patients given their underlying coagulopathic status with attention now being paid to NOACs and LMWH. For patients with bowel ischemia, extensive thrombosis, contraindications or poor response to AC, or for those with co-morbidities that preclude AC, minimally invasive endovascular techniques offer alternative treatment options. Conclusion: Familiarity with the etiology, clinical presentation and classification of PVT optimize early detection and incorporate effective therapeutic options, the management of these complex patients should be undertaken by a multidisciplinary team. Minimally invasive catheter-based therapies and endovascular portosystemic shunt creation demonstrated efficacy in the treatment of AC-resistant patients and for patients with extensive or complicated disease.",
keywords = "Portal hypertension, Portal vein thrombosis, Transsplenic",
author = "Sadeer Alzubaidi and Indravadan Patel and Aman Saini and Grace Knuttinen and Sailendra Naidu and Scott Kriegshuaser and Hassan Albadawi and Rahmi Oklu",
year = "2019",
month = "1",
day = "1",
doi = "10.1007/s00261-019-02174-1",
language = "English (US)",
journal = "Abdominal Radiology",
issn = "2366-004X",
publisher = "Springer New York",

}

TY - JOUR

T1 - Current concepts in portal vein thrombosis

T2 - etiology, clinical presentation and management

AU - Alzubaidi, Sadeer

AU - Patel, Indravadan

AU - Saini, Aman

AU - Knuttinen, Grace

AU - Naidu, Sailendra

AU - Kriegshuaser, Scott

AU - Albadawi, Hassan

AU - Oklu, Rahmi

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Objective: The aim of this article is to focus on etiology, risk factors, clinical presentation and classification systems of acute and chronic PVT as well as focusing on current diagnostic and therapeutic options for the management of acute and chronic PVT. Results: PVT represents a serious clinical concern in cirrhotic patients and in those with specific local or systemic risk factors. The rate and extent of thrombus formation can significantly impact patient presentation and the resulting clinical outcomes. The presentation of acute PVT can range from abdominal pain to intestinal ischemia/infarction and even death, while chronic PVT can remain clinically silent. A number of imaging modalities including US, CT and MRI can be used to confirm the diagnosis. In addition to addressing underlying risk factors, AC therapy forms a cornerstone of treatment and has demonstrated efficacy in both acute and chronic settings. Proper caution should be used when initiating AC therapy in cirrhotic patients given their underlying coagulopathic status with attention now being paid to NOACs and LMWH. For patients with bowel ischemia, extensive thrombosis, contraindications or poor response to AC, or for those with co-morbidities that preclude AC, minimally invasive endovascular techniques offer alternative treatment options. Conclusion: Familiarity with the etiology, clinical presentation and classification of PVT optimize early detection and incorporate effective therapeutic options, the management of these complex patients should be undertaken by a multidisciplinary team. Minimally invasive catheter-based therapies and endovascular portosystemic shunt creation demonstrated efficacy in the treatment of AC-resistant patients and for patients with extensive or complicated disease.

AB - Objective: The aim of this article is to focus on etiology, risk factors, clinical presentation and classification systems of acute and chronic PVT as well as focusing on current diagnostic and therapeutic options for the management of acute and chronic PVT. Results: PVT represents a serious clinical concern in cirrhotic patients and in those with specific local or systemic risk factors. The rate and extent of thrombus formation can significantly impact patient presentation and the resulting clinical outcomes. The presentation of acute PVT can range from abdominal pain to intestinal ischemia/infarction and even death, while chronic PVT can remain clinically silent. A number of imaging modalities including US, CT and MRI can be used to confirm the diagnosis. In addition to addressing underlying risk factors, AC therapy forms a cornerstone of treatment and has demonstrated efficacy in both acute and chronic settings. Proper caution should be used when initiating AC therapy in cirrhotic patients given their underlying coagulopathic status with attention now being paid to NOACs and LMWH. For patients with bowel ischemia, extensive thrombosis, contraindications or poor response to AC, or for those with co-morbidities that preclude AC, minimally invasive endovascular techniques offer alternative treatment options. Conclusion: Familiarity with the etiology, clinical presentation and classification of PVT optimize early detection and incorporate effective therapeutic options, the management of these complex patients should be undertaken by a multidisciplinary team. Minimally invasive catheter-based therapies and endovascular portosystemic shunt creation demonstrated efficacy in the treatment of AC-resistant patients and for patients with extensive or complicated disease.

KW - Portal hypertension

KW - Portal vein thrombosis

KW - Transsplenic

UR - http://www.scopus.com/inward/record.url?scp=85070745727&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85070745727&partnerID=8YFLogxK

U2 - 10.1007/s00261-019-02174-1

DO - 10.1007/s00261-019-02174-1

M3 - Review article

C2 - 31407054

AN - SCOPUS:85070745727

JO - Abdominal Radiology

JF - Abdominal Radiology

SN - 2366-004X

ER -